Abdullah Nasser Alsuwaidan

Dr. Abdullah N. Alsuwaidan is a distinguished physician with an impressive educational and professional background. He obtained his medical degree from the College of Medicine at Imam Abdulrahman Bin Faisal University in Dammam, Saudi Arabia. Dr. Alsuwaidan's passion for pathology led him to complete his residency program at Creighton University Medical Center in Omaha, Nebraska in 2017.

Driven by his commitment to excellence, he pursued advanced training in the United States. He completed a Hematopathology fellowship at the University of Texas Southwestern Medical Center in Dallas, TX, and subsequently, a Molecular Genetic Pathology Fellowship at the University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pennsylvania. His dedication to continuous learning and professional growth is evidenced by his board certifications in Anatomic Pathology, Clinical Pathology, Hematopathology, and Molecular Genetic Pathology, awarded by the American Board of Pathology. In addition to his impressive medical credentials, he also holds a Master's degree in Business Administration (MBA) with a focus on Healthcare Management from Alfaisal University, Riyadh, KSA.

Currently, Dr. Alsuwaidan holds the position of Chairman, Clinical Genomics Department at the Centre for Genomic Medicine (CGM), King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh. In this role, he oversees the molecular genetics laboratory, which includes next-generation sequencing for hereditary and cancer genetics. Dr. Alsuwaidan's expertise encompasses a wide range of areas, with special interests in precision medicine application such as hereditary cancer, breast cancer, thyroid cancer, lymphoma, and leukemia.

His illustrious career is marked by a commitment to advancing medical knowledge and providing exceptional care. Dr. Alsuwaidan's contributions to the field of genomics and pathology are a testament to his dedication and unwavering pursuit of excellence.

.

Abdullah Alsuwaidan, M.D.